查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447156

冷痛治療市場：按產品、應用、通路：2023-2032 年全球機會分析與產業預測

Cold Pain Therapy Market By Product, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 240 Pages | 商品交期: 2-3個工作天內

價格

2022年冷痛療法市場價值為19億美元，預計到2032年將達到30.4億美元，2023年至2032年的複合年成長率為5.1%。

冷凍療法是指冷療法。冷凍療法有許多不同的方法，包括冰袋、冷卻噴霧、冰按摩、熱水浴缸和冰浴。當用於在家治療受傷時，冷凍療法通常是指使用冰塊或凝膠袋進行冷療，將其保存在冷凍庫中直至需要。這些是一些最簡單且經過時間考驗的疼痛和腫脹治療方法。

冷療可以幫助減輕發炎。當用於急性損傷和疼痛時最有效。它有助於減緩關節和肌腱周圍組織的損傷速度。冷凍療法可以麻痺酸痛的肌肉組織，其作用幾乎就像麻醉劑一樣。它還具有減緩疼痛訊號傳輸到大腦的作用。冷敷是 RICE（休息、冰敷、壓迫、抬高）的一部分，是治療標準傷害的常見家庭治療方法。

推動全球冷痛治療市場成長的主要因素包括肌肉骨骼疾病、關節炎、骨關節炎、關節疾病等的增加，從而導致更先進和易於使用的冷痛治療產品的開發。技術進步的擴散。此外，人口老化的加劇以及對長期使用止痛藥相關潛在副作用和風險的認知不斷提高，是推動非藥物疼痛管理需求和市場成長的關鍵因素。此外，主要市場參與者的增加及其開發技術先進的冷痛治療產品所採取的策略是推動冷痛治療市場成長的主要因素。

例如，2023 年 3 月，行動和疼痛管理解決方案行業領導者 Aspen Medical Products (Aspen) 與運動和損傷恢復系統領先提供商 NICE Recovery Systems (NICE) 宣布結成戰略聯盟，旨在為患者提供醫療保健專業人員提供更好的恢復和疼痛管理解決方案。該合作夥伴關係利用 NICE 先進的冷壓縮技術和 Aspen 有效的矯正器具解決方案，為從手術或受傷中恢復的患者提供疼痛管理和術後護理。

然而，擴大使用低成本止痛藥來立即緩解疼痛，缺乏有利的報銷限制了冷痛療法市場的成長。相反，擴大採用止痛貼片預計將為預測期內冷痛治療市場的成長提供利潤豐厚的機會。

冷痛療法市場分為產品、應用、通路和地區。從產品角度來看，市場分為非處方藥產品和處方藥產品。 OTC產品進一步細分為乳膏劑、凝膠劑、貼片等，處方箋產品進一步細分為電動和非電動裝置。根據應用，它們分為肌肉骨骼疾病、術後治療、運動傷害和創傷後治療。依銷售管道分為醫院藥局、零售藥局、網路藥局。

按地區分類，北美（美國、加拿大、墨西哥）、歐洲（德國、英國、英國、義大利、西班牙、其他歐洲國家地區）、亞太地區（中國、日本、澳洲、印度、韓國、其他亞太地區） ）、拉丁美洲分析美洲（巴西、哥倫比亞、阿根廷和其他亞太地區）、中東美洲（海灣合作理事會、哥倫比亞、阿根廷和其他南美地區）。

相關人員的主要利益

  • 本報告定量分析了 2022 年至 2032 年冷​​痛療法市場分析的細分市場、當前趨勢、估計/趨勢和動態，以確定一般冷痛療法市場機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商-買家網路的力量。
  • 冷痛療法市場區隔的詳細分析有助於識別市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前地位的清晰了解。
  • 該報告包括對區域和全球冷痛療法市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

其他購買優惠包括：

  • 季度更新和*（僅限公司許可證，按標價提供）
  • 在購買之前或之後免費更新您選擇的 5 個額外公司簡介。
  • 如果您購買 5 使用者許可證或企業使用者許可證，將免費提供下一個版本。
  • 16 小時分析師支援*（購買後，如果您的報表審查顯示有額外的資料需求，您將獲得 16 小時分析師支持，以解決任何問題或售後查詢。）
  • 15% 免費自訂*（如果報告的範圍或部分不符合您的要求，15% 相當於 3 個工作日的免費工作。）
  • 5 個用戶許可證和企業用戶許可證的免費資料包。 （Excel版報告）
  • 如果您的報告超過 6-12 個月，我們將免費提供更新的報告。
  • 24 小時優先回應*。
  • 免費業界更新和白皮書
    冷痛治療市場-IMG1
  • 該報告可以客製化（需要單獨的成本和時間表）。
  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 與運動相關的傷害增加。
      • 手術次數增加。
      • 外傷案件增加。
    • 抑制因素
      • 提供低成本止痛藥來緩解疼痛。
    • 機會
      • 肌肉骨骼疾病的盛行率上升。

第4章冷痛治療市場：依產品

  • 概述
  • 非處方藥產品
    • 按非處方藥產品類型分類的冷痛治療市場
  • 處方產品
    • 按處方產品類型分類的冷痛治療市場

第5章冷痛治療市場：依應用分類

  • 概述
  • 肌肉骨骼疾病
  • 術後治療
  • 運動傷害
  • 創傷後治療

第6章冷痛治療市場：依通路分類

  • 概述
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第7章冷痛治療市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 巴西
    • 哥倫比亞
    • 阿根廷
    • 其他拉丁美洲
  • 中東/非洲
    • Gcc
    • 南非
    • 北非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Cardinal Health Inc.
  • Sanofi
  • Medline Industries, LP
  • Beiersdorf AG
  • ThermoTek Inc
  • 3M Company
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Bruder Healthcare Company LLC
  • Ossur
  • Romsons Group of Industries Pvt. Ltd.
Product Code: A09540

The cold pain therapy market was valued at $1.9 billion in 2022 and is estimated to reach $3.04 billion by 2032, exhibiting a CAGR of 5.1%from 2023 to 2032.

Cryotherapy means cold therapy. Cryotherapy can be applied in various ways, including icepacks, coolant sprays, ice massage, and whirlpools, or ice baths. When used to treat injuries at home, cryotherapy refers to cold therapy with ice or gel packs that are usually kept in the freezer until needed. These remain one of the simplest, time-tested remedies for managing pain and swelling.

Cold therapy helps reduce inflammation. It's most helpful when used for acute injuries and pain. It aids in slowing the rate of reducing tissue damage around a joint or tendon. Cold therapy can numb sore muscle tissue, almost acting as an anesthetic. It has the ability to slow down the pain signals that are transmitted to the brain. Cold compresses are part of a common at-home treatment for standard injuries - RICE - Rest, ice, compression, elevation.

Major factors that drive the growth of the global cold pain therapy market include a rise in the number of musculoskeletal disorders, arthritis, osteoarthritis, joint disorders and others, upsurge in technological advancement that have led to the development of more sophisticated and user-friendly cold pain therapy products. Furthermore, the growing aging population and growing awareness of the potential side effects and risks associated with long-term use of pain medications are the major factors that increase the demand for non-pharmacological pain management and hence propel the growth of the market. In addition, the increase in the number of key market players and the strategies they adopt for the development of technologically advanced cold pain therapy products are the major factors that boost the growth of the cold pain therapy market.

For instance, in March 2023, Aspen Medical Products (Aspen), the industry leader in solutions for mobility and pain management, and NICE Recovery Systems (NICE), a leading provider in the sports and injury recovery space, announced a strategic partnership that aims to bring more precise recovery and pain management solutions to patients and medical professionals. The partnership leverages NICE's advanced cold compression technology with Aspen's effective bracing solutions to deliver pain management and post-operative care to patients recovering from surgery or injury.

However, the growing use of low-priced analgesic pills for immediate pain relief and lack of favorable reimbursement restrain the growth of the cold pain therapy market. On the contrary, the increase in the adoption of analgesic patches is expected to provide lucrative opportunities for the cold pain therapy market to grow during the forecast period.

The cold pain therapy market is segmented into product, application, distribution channel, and region. On the basis of product, the market is bifurcated into OTC products and prescription products. The OTC products are further bifurcated into creams, gels, patches and others and the prescription products are sub-segmented into motorized devices and non-motorized devices. On the basis of application, it is segregated into musculoskeletal disorders, post-operative therapies, sport injuries and post-trauma therapy. On the basis of distribution channel, it is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and Latin America (Brazil, Colombia, Argentina, Rest of LA) and Middle East and Africa (GCC, South Africa, North Africa, Rest of MEA)

The major players profiled in the report are Romsons Group of Industries, Cardinal Health Inc, Sanofi, Breg Inc., Medline Industries LP, Ossur, Hisamitsu Pharmaceutical Inc, Beiersdorf AG, 3M and ThermoTek Inc. The key players such as ThermoTek Inc and Hisamitsu Pharmaceutical Inc have adopted expansion as major developmental strategies to improve the product portfolio

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cold pain therapy market analysis from 2022 to 2032 to identify the prevailing cold pain therapy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cold pain therapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cold pain therapy market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.
    Cold Pain Therapy Market - IMG1
  • Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • OTC Products
    • Type
    • Creams
    • Gels
    • Patches
    • Others
  • Prescription Products
    • Type
    • Motorized Devices
    • Non Motorized Devices

By Application

  • Musculoskeletal Disorders
  • Post-Operative Therapy
  • Sports Injuries
  • Post-Trauma Therapy

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Sanofi
    • Beiersdorf AG
    • 3M Company
    • Medline Industries, LP
    • Ossur
    • Romsons Group of Industries Pvt. Ltd.
    • Cardinal Health Inc.
    • ThermoTek Inc
    • Hisamitsu Pharmaceutical Co.,Inc.
    • Bruder Healthcare Company LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the number of sports related injuries.
      • 3.4.1.2. Increase in the number of surgical procedures.
      • 3.4.1.3. Rise in the number of traumatic injury cases.
    • 3.4.2. Restraints
      • 3.4.2.1. Availability of low-priced analgesic pills for pain relief
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in the prevalence of musculoskeletal disorders.

CHAPTER 4: COLD PAIN THERAPY MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. OTC Products
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. OTC Products Cold Pain Therapy Market by Type
  • 4.3. Prescription Products
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Prescription Products Cold Pain Therapy Market by Type

CHAPTER 5: COLD PAIN THERAPY MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Musculoskeletal Disorders
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Post-Operative Therapy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Sports Injuries
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Post-Trauma Therapy
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals Pharmacies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Retail Pharmacies
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Online Pharmacies
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: COLD PAIN THERAPY MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by Distribution Channel
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by Distribution Channel
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by Distribution Channel
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by Distribution Channel
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by Distribution Channel
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by Distribution Channel
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by Distribution Channel
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by Distribution Channel
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by Distribution Channel
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by Distribution Channel
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by Distribution Channel
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by Distribution Channel
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by Distribution Channel
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by Distribution Channel
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by Distribution Channel
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by Distribution Channel
  • 7.5. Latin America
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by Distribution Channel
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by Distribution Channel
      • 7.5.5.2. Colombia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by Distribution Channel
      • 7.5.5.3. Argentina
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by Distribution Channel
      • 7.5.5.4. Rest of Latin America
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by Distribution Channel
  • 7.6. Middle East and Africa
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by Product
    • 7.6.3. Market size and forecast, by Application
    • 7.6.4. Market size and forecast, by Distribution Channel
    • 7.6.5. Market size and forecast, by country
      • 7.6.5.1. Gcc
      • 7.6.5.1.1. Market size and forecast, by Product
      • 7.6.5.1.2. Market size and forecast, by Application
      • 7.6.5.1.3. Market size and forecast, by Distribution Channel
      • 7.6.5.2. South Africa
      • 7.6.5.2.1. Market size and forecast, by Product
      • 7.6.5.2.2. Market size and forecast, by Application
      • 7.6.5.2.3. Market size and forecast, by Distribution Channel
      • 7.6.5.3. North Africa
      • 7.6.5.3.1. Market size and forecast, by Product
      • 7.6.5.3.2. Market size and forecast, by Application
      • 7.6.5.3.3. Market size and forecast, by Distribution Channel
      • 7.6.5.4. Rest Of Mea
      • 7.6.5.4.1. Market size and forecast, by Product
      • 7.6.5.4.2. Market size and forecast, by Application
      • 7.6.5.4.3. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cardinal Health Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Sanofi
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Medline Industries, LP
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Beiersdorf AG
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. ThermoTek Inc
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. 3M Company
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. Hisamitsu Pharmaceutical Co.,Inc.
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Bruder Healthcare Company LLC
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Ossur
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Romsons Group of Industries Pvt. Ltd.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL OTC PRODUCTS COLD PAIN THERAPY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL PRESCRIPTION PRODUCTS COLD PAIN THERAPY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 07. COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 12. COLD PAIN THERAPY MARKET FOR HOSPITALS PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. COLD PAIN THERAPY MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. COLD PAIN THERAPY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 20. U.S. COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. U.S. COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. U.S. COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 23. CANADA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. CANADA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. CANADA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 39. UK COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. UK COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. UK COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 42. ITALY COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. ITALY COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. ITALY COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 58. CHINA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. CHINA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. CHINA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 61. INDIA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. INDIA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. INDIA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 73. LATIN AMERICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. LATIN AMERICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. LATIN AMERICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 76. LATIN AMERICA COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 80. COLOMBIA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. COLOMBIA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. COLOMBIA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 83. ARGENTINA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. ARGENTINA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. ARGENTINA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 89. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 92. MIDDLE EAST AND AFRICA COLD PAIN THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 93. GCC COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. GCC COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. GCC COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. SOUTH AFRICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. SOUTH AFRICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 99. NORTH AFRICA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. NORTH AFRICA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. NORTH AFRICA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 102. REST OF MEA COLD PAIN THERAPY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. REST OF MEA COLD PAIN THERAPY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. REST OF MEA COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 105. CARDINAL HEALTH INC.: KEY EXECUTIVES
  • TABLE 106. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 107. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
  • TABLE 108. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 109. SANOFI: KEY EXECUTIVES
  • TABLE 110. SANOFI: COMPANY SNAPSHOT
  • TABLE 111. SANOFI: PRODUCT SEGMENTS
  • TABLE 112. SANOFI: PRODUCT PORTFOLIO
  • TABLE 113. MEDLINE INDUSTRIES, LP: KEY EXECUTIVES
  • TABLE 114. MEDLINE INDUSTRIES, LP: COMPANY SNAPSHOT
  • TABLE 115. MEDLINE INDUSTRIES, LP: PRODUCT SEGMENTS
  • TABLE 116. MEDLINE INDUSTRIES, LP: PRODUCT PORTFOLIO
  • TABLE 117. BEIERSDORF AG: KEY EXECUTIVES
  • TABLE 118. BEIERSDORF AG: COMPANY SNAPSHOT
  • TABLE 119. BEIERSDORF AG: PRODUCT SEGMENTS
  • TABLE 120. BEIERSDORF AG: PRODUCT PORTFOLIO
  • TABLE 121. THERMOTEK INC: KEY EXECUTIVES
  • TABLE 122. THERMOTEK INC: COMPANY SNAPSHOT
  • TABLE 123. THERMOTEK INC: PRODUCT SEGMENTS
  • TABLE 124. THERMOTEK INC: PRODUCT PORTFOLIO
  • TABLE 125. 3M COMPANY: KEY EXECUTIVES
  • TABLE 126. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 127. 3M COMPANY: PRODUCT SEGMENTS
  • TABLE 128. 3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 129. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY EXECUTIVES
  • TABLE 130. HISAMITSU PHARMACEUTICAL CO.,INC.: COMPANY SNAPSHOT
  • TABLE 131. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT SEGMENTS
  • TABLE 132. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT PORTFOLIO
  • TABLE 133. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY STRATERGIES
  • TABLE 134. BRUDER HEALTHCARE COMPANY LLC: KEY EXECUTIVES
  • TABLE 135. BRUDER HEALTHCARE COMPANY LLC: COMPANY SNAPSHOT
  • TABLE 136. BRUDER HEALTHCARE COMPANY LLC: PRODUCT SEGMENTS
  • TABLE 137. BRUDER HEALTHCARE COMPANY LLC: PRODUCT PORTFOLIO
  • TABLE 138. OSSUR: KEY EXECUTIVES
  • TABLE 139. OSSUR: COMPANY SNAPSHOT
  • TABLE 140. OSSUR: PRODUCT SEGMENTS
  • TABLE 141. OSSUR: PRODUCT PORTFOLIO
  • TABLE 142. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: KEY EXECUTIVES
  • TABLE 143. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 144. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: PRODUCT SEGMENTS
  • TABLE 145. ROMSONS GROUP OF INDUSTRIES PVT. LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. COLD PAIN THERAPY MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF COLD PAIN THERAPY MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN COLD PAIN THERAPY MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN COLD PAIN THERAPY MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL COLD PAIN THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. COLD PAIN THERAPY MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COLD PAIN THERAPY MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR HOSPITALS PHARMACIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF COLD PAIN THERAPY MARKET FOR ONLINE PHARMACIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COLD PAIN THERAPY MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. COLOMBIA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. ARGENTINA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LATIN AMERICA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. GCC COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. NORTH AFRICA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF MEA COLD PAIN THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR (2021)
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021)
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY (2021)
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: COLD PAIN THERAPY MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022
  • FIGURE 54. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 55. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 56. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. SANOFI: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. SANOFI: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. SANOFI: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. BEIERSDORF AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. BEIERSDORF AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. BEIERSDORF AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 66. HISAMITSU PHARMACEUTICAL CO.,INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. OSSUR: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. OSSUR: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 69. OSSUR: REVENUE SHARE BY REGION, 2022 (%)